Annotation Detail

Information
Associated Genes
MYC
Associated Variants
MYC OVEREXPRESSION
MYC OVEREXPRESSION
Associated Disease
multiple myeloma
Source Database
CIViC Evidence
Description
BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes. In experimental models of multiple myeloma, a Myc-dependent hematologic malignancy, JQ1 produces a potent antiproliferative effect associated with cell-cycle arrest and cellular senescence.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/5505
Gene URL
https://civic.genome.wustl.edu/links/genes/3737
Variant URL
https://civic.genome.wustl.edu/links/variants/1303
Rating
5
Evidence Type
Predictive
Disease
Multiple Myeloma
Evidence Direction
Supports
Drug
JQ-1
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
21889194
Drugs
Drug NameSensitivitySupported
JQ-1Sensitivitytrue